Bogart Wealth’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
Bogart Wealth's UNCY Position: Q3 2026 in Review
Bogart Wealth sold out of Unicycive Therapeutics (UNCY) in Q3 2026, closing a stake of 6 shares — an estimated $28 sold.
Bogart Wealth first reported a position in UNCY in Q4 2024 and held it in 7 quarters. The position peaked at $48 in Q4 2024. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Bogart Wealth reported no remaining Unicycive Therapeutics position as of Q3 2026 after selling out during the quarter.
- Bogart Wealth sold 6 Unicycive Therapeutics shares in Q3 2026, an estimated $28.
- Bogart Wealth first reported a position in Unicycive Therapeutics in Q4 2024 and held it in 7 quarters.
- Bogart Wealth's Unicycive Therapeutics position peaked at $48 in Q4 2024.
- 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.